Fig. 3. Immunohistochemically, majority of the lymphocytes
expressed CD3, CD5, & CD4, (A, B, C); a few CD8+ cells, low Ki67
(10%), & CD30 negativity (D,E,F) (x40).
Refrences :
1. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al.
WHO-EORTC classification for cutaneous lymphomas. Blood.
2005;105(10):3768-85.
2. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et
al. The 2016 revision of the World Health Organization classification of
lymphoid neoplasms. Blood, The Journal of the American Society of
Hematology. 2016;127(20):2375-90.
3. Beltraminelli H, Leinweber B, Kerl H, Cerroni L. Primary cutaneous
CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous
nodular proliferation of pleomorphic T lymphocytes of undetermined
significance? A study of 136 cases. The American Journal of
dermatopathology. 2009;31(4):317-22.
4. Gru AA, Wick MR, Eid M. Primary cutaneous CD4+ small/medium T-cell
lymphoproliferative disorder-clinical and histopathologic features,
differential diagnosis, and treatment. Semin Cutan Med Surg.
2018;37(1):39-48.
5. Baum CL, Link BK, Neppalli VT, Swick BL, Liu V. Reappraisal of the
provisional entity primary cutaneous CD4+ small/medium pleomorphic
T-cell lymphoma: a series of 10 adult and pediatric patients and review
of the literature. Journal of the American Academy of Dermatology.
2011;65(4):739-48.
6. Kim J, Jeong M, Jun D, Lee M, Shin D, Kim W, et al. Primary cutaneous
CD4+ small/medium T-cell lymphoma: a case report. Archives of
Craniofacial Surgery. 2021;22(4):199.
7. Salah E. Primary cutaneous CD4+ small/medium pleomorphic T-cell
lymphoproliferative disorder: Where do we stand? A systematic review.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the
German Society of Dermatology : JDDG. 2019;17(2):123-36.
8. Escanilla C, Guavita Falla PM, Cevallos C, Ávalos Jobet N, Bobadilla
Bruneau F. Primary cutaneous CD4-positive small/medium T-cell
lymphoproliferative disorder: The first-reported Latin-American case
with response to doxycycline. Clinical case reports. 2019;7(12):2405-9.
9. Li D, Guo B, Li D, Chang C, Lu Q. Primary cutaneous CD4+
small-to-medium-sized pleomorphic T-cell lymphoma: a rare case report of
infant. Journal of clinical pathology. 2015;68(10):855-8.
10. Grogg KL, Jung S, Erickson LA, McClure RF, Dogan A. Primary
cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a
clonal T-cell lymphoproliferative disorder with indolent behavior.
Modern pathology : an official journal of the United States and Canadian
Academy of Pathology, Inc. 2008;21(6):708-15.
11. Messeguer F, Gimeno E, Agusti-Mejias A, San Juan J. [Primary
cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma:
report of a case with spontaneous resolution]. Actas
dermo-sifiliograficas. 2011;102(8):636-8.
12. González Fernández D, Valdés Pineda F, Gómez Díez S, Vivanco Allende
B. Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoma With
Spontaneous Regression After Biopsy. Actas dermo-sifiliograficas.
2015;106(9):767-8.
13. Friedmann D, Wechsler J, Delfau MH, Estève E, Farcet JP, de Muret A,
et al. Primary cutaneous pleomorphic small T-cell lymphoma. A review of
11 cases. The French Study Group on Cutaneous Lymphomas. Archives of
dermatology. 1995;131(9):1009-15.